Segment Reporting (Tables)

3 Months Ended

Nov. 30, 2015

Segment Reporting [Abstract]

Reconciliation of Revenue from Segments to Consolidated

The following table reflects results of operations of the Company’s reportable segments (in millions):

	Retail Pharmacy				Pharmaceutical Wholesale		Eliminations and Unallocated Items			Consolidated
	USA		International
Three Months Ended November 30, 2015
Sales to external customers	$	20,370	$	3,459	$	5,204	$	—		$	29,033
Intersegment sales		—		72		592		(664	)		—
Total Sales		20,370		3,531		5,796		(664	)		29,033
Adjusted Operating Income	$	1,243	$	315	$	166	$	(5	)	$	1,719
Three Months Ended November 30, 2014
Sales to external customers	$	19,554	$	—	$	—	$	—		$	19,554
Intersegment sales		—		—		—		—			—
Total Sales		19,554		—		—		—			19,554
Adjusted Operating Income	$	1,118	$	—	$	—	$	—		$	1,118

Reconciliation of Operating Profit (Loss) from Segments to Consolidated

The following table reconciles adjusted operating income to operating income (in millions):

	Retail Pharmacy				Pharmaceutical Wholesale		Eliminations and Unallocated Items			Consolidated
	USA		International
Three Months Ended November 30, 2015
Adjusted Operating Income	$	1,243	$	315	$	166	$	(5	)	$	1,719
Cost transformation											(90	)
Acquisition-related amortization											(81	)
LIFO provision											(46	)
Acquisition-related costs											(34	)
Operating Income										$	1,468
Three Months Ended November 30, 2014
Adjusted Operating Income	$	1,118	$	—	$	—	$	—		$	1,118
Acquisition-related amortization											(89	)
LIFO provision											(52	)
Store closures and other optimization costs											(28	)
Acquisition-related costs											(24	)
Increase in fair market value of warrants											129
Operating Income										$	1,054